TransThera Sciences (Nanjing), Inc. (02617) published its Monthly Return on Movements in Securities for the period ended 30 November 2025. According to the announcement, the company's authorized share capital remained RMB 396,897,633, comprising 301,666,673 H shares and 95,230,960 unlisted shares, each with a par value of RMB 1. No changes were reported in either category during the month.
The total number of issued H shares remained at 301,666,673, while unlisted shares stood at 95,230,960. No share issuances, cancellations, or share repurchases were recorded. The announcement was submitted on 02 December 2025.
Comments